While primary tumor cells express predominantly genes encoding EDG‐type receptors (LPA1‐3), immune cells (TAMs and TATs) also express genes for the non‐EDG receptors LPAR5 and LPAR6 at high levels (Fig. 6). This evidence concerns the gene LPAR6 and neoplasm.